SHH and Miyoshi myopathy: Moreover, our in vitro evidences uncover a novel axis between PCs and MSCs that leads to the suppression of the SHH signaling pathway in MSCs, thus, further reducing the endogenous potential to compensate for osteolytic complications of MM.